BlackRock’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,972,924
Closed -$684M 5833
2021
Q3
$684M Sell
3,972,924
-430,301
-10% -$74.1M 0.02% 761
2021
Q2
$553M Sell
4,403,225
-225,753
-5% -$28.3M 0.02% 938
2021
Q1
$628M Buy
4,628,978
+17,164
+0.4% +$2.33M 0.02% 821
2020
Q4
$590M Sell
4,611,814
-29,191
-0.6% -$3.73M 0.02% 781
2020
Q3
$522M Buy
4,641,005
+204,593
+5% +$23M 0.02% 725
2020
Q2
$423M Sell
4,436,412
-682,889
-13% -$65.1M 0.02% 823
2020
Q1
$460M Buy
5,119,301
+231,500
+5% +$20.8M 0.02% 638
2019
Q4
$259M Sell
4,887,801
-287,757
-6% -$15.3M 0.01% 1275
2019
Q3
$204M Buy
5,175,558
+253,678
+5% +$10M 0.01% 1385
2019
Q2
$202M Buy
4,921,880
+124,369
+3% +$5.11M 0.01% 1425
2019
Q1
$223M Buy
4,797,511
+368,617
+8% +$17.2M 0.01% 1334
2018
Q4
$193M Buy
4,428,894
+81,002
+2% +$3.53M 0.01% 1338
2018
Q3
$249M Buy
4,347,892
+142,823
+3% +$8.17M 0.01% 1309
2018
Q2
$204M Buy
4,205,069
+175,010
+4% +$8.49M 0.01% 1436
2018
Q1
$158M Sell
4,030,059
-702,076
-15% -$27.5M 0.01% 1531
2017
Q4
$201M Buy
4,732,135
+434,123
+10% +$18.4M 0.01% 1367
2017
Q3
$160M Buy
4,298,012
+292,784
+7% +$10.9M 0.01% 1521
2017
Q2
$122M Buy
4,005,228
+330,635
+9% +$10M 0.01% 1670
2017
Q1
$97.3M Buy
3,674,593
+3,595,733
+4,560% +$95.2M 0.01% 1792
2016
Q4
$2.01M Buy
78,860
+43,820
+125% +$1.12M ﹤0.01% 1208
2016
Q3
$1.27M Sell
35,040
-541
-2% -$19.6K ﹤0.01% 1368
2016
Q2
$1.21M Buy
35,581
+1,899
+6% +$64.5K ﹤0.01% 1334
2016
Q1
$889K Buy
33,682
+4,887
+17% +$129K ﹤0.01% 1369
2015
Q4
$1.4M Sell
28,795
-4,700
-14% -$229K ﹤0.01% 1193
2015
Q3
$834K Buy
33,495
+400
+1% +$9.96K ﹤0.01% 1339
2015
Q2
$1.05M Sell
33,095
-788
-2% -$24.9K ﹤0.01% 1316
2015
Q1
$1.29M Buy
33,883
+1,600
+5% +$60.9K ﹤0.01% 1218
2014
Q4
$1.26M Buy
32,283
+31,900
+8,329% +$1.24M ﹤0.01% 1155
2014
Q3
$12K Hold
383
﹤0.01% 2579
2014
Q2
$13K Buy
383
+182
+91% +$6.18K ﹤0.01% 2580
2014
Q1
$7K Buy
+201
New +$7K ﹤0.01% 2931